69 related articles for article (PubMed ID: 9007151)
1. Esterase inhibitors diminish the modulation of gene expression by butyric acid derivative, pivaloyloxymethyl butyrate (AN-9).
Rabizadeh E; Shaklai M; Eisenbach L; Nudelman A; Rephaeli A
Isr J Med Sci; 1996 Dec; 32(12):1186-91. PubMed ID: 9007151
[TBL] [Abstract][Full Text] [Related]
2. Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line.
Aviram A; Zimrah Y; Shaklai M; Nudelman A; Rephaeli A
Int J Cancer; 1994 Mar; 56(6):906-9. PubMed ID: 8119779
[TBL] [Abstract][Full Text] [Related]
3. The role of intracellularly released formaldehyde and butyric acid in the anticancer activity of acyloxyalkyl esters.
Nudelman A; Levovich I; Cutts SM; Phillips DR; Rephaeli A
J Med Chem; 2005 Feb; 48(4):1042-54. PubMed ID: 15715472
[TBL] [Abstract][Full Text] [Related]
4. Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cells.
Aviram A; Rephaeli A; Shaklai M; Nudelman A; Ben-Dror I; Maron L; Rabizadeh E
J Cancer Res Clin Oncol; 1997; 123(5):267-71. PubMed ID: 9201249
[TBL] [Abstract][Full Text] [Related]
5. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
Chen ZX; Breitman TR
Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972
[TBL] [Abstract][Full Text] [Related]
6. Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug.
Rabizadeh E; Shaklai M; Nudelman A; Eisenbach L; Rephaeli A
FEBS Lett; 1993 Aug; 328(3):225-9. PubMed ID: 8348968
[TBL] [Abstract][Full Text] [Related]
7. Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis.
Zimra Y; Nudelman A; Zhuk R; Rabizadeh E; Shaklai M; Aviram A; Rephaeli A
J Cancer Res Clin Oncol; 2000 Dec; 126(12):693-8. PubMed ID: 11153141
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells.
Herold KM; Rothberg PG
Oncogene; 1988 Oct; 3(4):423-8. PubMed ID: 3078950
[TBL] [Abstract][Full Text] [Related]
9. Changes in Hox1.6, c-jun, and Oct-3 gene expressions are associated with teratocarcinoma F9 cell differentiation in three different ways of induction.
Iwai SA; Kosaka M; Nishina Y; Sumi T; Sakuda M; Nishimune Y
Exp Cell Res; 1993 Mar; 205(1):39-43. PubMed ID: 8453995
[TBL] [Abstract][Full Text] [Related]
10. Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells.
Zimra Y; Wasserman L; Maron L; Shaklai M; Nudelman A; Rephaeli A
J Cancer Res Clin Oncol; 1997; 123(3):152-60. PubMed ID: 9119880
[TBL] [Abstract][Full Text] [Related]
11. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1.
Litvak DA; Evers BM; Hwang KO; Hellmich MR; Ko TC; Townsend CM
Surgery; 1998 Aug; 124(2):161-9; discussion 169-70. PubMed ID: 9706134
[TBL] [Abstract][Full Text] [Related]
12. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
Bullock G; Ray S; Reed J; Miyashita T; Maria Ibrado A; Huang Y; Bhalla K
Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016
[TBL] [Abstract][Full Text] [Related]
13. Modulation of heat-shock protein 70 (HSP70) gene expression by sodium butyrate in U-937 promonocytic cells: relationships with differentiation and apoptosis.
Garcia-Bermejo L; Vilaboa NE; Perez C; Galan A; De Blas E; Aller P
Exp Cell Res; 1997 Oct; 236(1):268-74. PubMed ID: 9344607
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of 17 structural analogues of n-butyric acid upon c-myc expression.
Rottleb C; Hall C; Bornkamm GW; Polack A
Int J Cancer; 1996 Sep; 67(5):724-9. PubMed ID: 8782665
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies.
Patnaik A; Rowinsky EK; Villalona MA; Hammond LA; Britten CD; Siu LL; Goetz A; Felton SA; Burton S; Valone FH; Eckhardt SG
Clin Cancer Res; 2002 Jul; 8(7):2142-8. PubMed ID: 12114414
[TBL] [Abstract][Full Text] [Related]
16. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
17. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced by the sodium butyrate in human gastric cancer TMK-1 cells.
Tsai LC; Hung MW; Chang GG; Chang TC
Anticancer Res; 2000; 20(4):2441-8. PubMed ID: 10953308
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A
Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251
[TBL] [Abstract][Full Text] [Related]
20. Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.
Wilson AJ; Velcich A; Arango D; Kurland AR; Shenoy SM; Pezo RC; Levsky JM; Singer RH; Augenlicht LH
Cancer Res; 2002 Nov; 62(21):6006-10. PubMed ID: 12414619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
